tiprankstipranks
Aequus Pharmaceuticals Inc (TSE:AQS)
:AQS
Canadian Market

Aequus Pharmaceuticals (AQS) Income Statement

Compare
13 Followers

Aequus Pharmaceuticals Income Statement

Last quarter (Q3 2024), Aequus Pharmaceuticals's total revenue was C$148.32K, an increase of 1010.26% from the same quarter last year. In Q3, Aequus Pharmaceuticals's net income was C$-614.73K. See Aequus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 254.90KC$ 1.38MC$ 2.71MC$ 2.59MC$ 1.63M
Gross Profit
C$ 5.50KC$ 1.15MC$ 2.69MC$ 2.59MC$ 1.63M
Operating Expenses
C$ 2.96MC$ 3.64MC$ 4.06MC$ 3.12MC$ 3.85M
Depreciation and Amortization
C$ 138.16KC$ 129.83KC$ 128.11KC$ 210.97KC$ 309.07K
EBITDA
C$ -2.68MC$ -2.87MC$ -1.23MC$ -314.80KC$ -2.38M
Operating Income
C$ -2.82MC$ -2.50MC$ -1.35MC$ -521.57KC$ -2.21M
Other Income/Expenses
C$ -144.44KC$ -712.01KC$ -442.14KC$ -519.26KC$ -888.21K
Pretax Income
C$ -2.96MC$ -3.21MC$ -1.81MC$ -1.05MC$ -3.11M
Net Income
C$ -2.96MC$ -3.21MC$ -1.81MC$ -1.05MC$ -3.11M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.02C$ -0.02C$ -0.01C$ -0.01C$ -0.04
Diluted EPS
C$ -0.02C$ -0.02C$ -0.01C$ -0.01C$ -0.04
Weighted Average Shares Outstanding
132.63M 132.63M 128.85M 93.18M 80.43M
Weighted Average Shares Outstanding (Diluted)
132.63M 132.63M 128.85M 93.18M 80.43M
Currency in CAD

Aequus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis